BPC-157 10MG ( Research Purposes Only )

Description

BPC-157 Overview and Research Summary

What is BPC-157?

BPC-157, also known as Body Protection Compound-157, is a synthetic pentadecapeptide derived from a protein found in the human digestive tract. It is currently under study for its potential roles in supporting tissue repair and promoting blood vessel growth in various preclinical and laboratory models. Research on BPC-157 focuses on its effects on cell migration, gene expression, and biochemical pathways relevant to tissue integrity.

BPC-157 is composed of 15 amino acids, and its potential biological properties have been explored in research related to:

• Tissue repair
• Angiogenesis (blood vessel growth)
• Coagulation pathways
• Nitric oxide production
• Immune response regulation
• Gene expression
• Gastrointestinal hormone modulation

BPC-157 Peptide Structure:

• Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
• Molecular Formula: C₆₂H₉₈N₁₅O₂₂
• Molecular Weight: 1419.556 g/mol
• PubChem CID: 108101

Research on BPC-157:

1. Tissue Repair Studies:
   Research into BPC-157 suggests its potential to support tissue integrity and healing, particularly within the gastrointestinal tract. Preclinical studies have shown that BPC-157 may affect fibroblast activity, a key player in the formation of extracellular matrix proteins like collagen. Studies have demonstrated a dose-dependent response in fibroblast proliferation and migration in both in vitro and in vivo research models.
2. Angiogenesis and Vascular Growth:
   In animal models, BPC-157 has shown potential to stimulate angiogenesis—the formation of new blood vessels. This is of interest to researchers studying the vascular response to tissue injury, including improved blood flow to damaged areas in experimental settings.
3. Connective Tissue Research:
   Research has investigated BPC-157’s effects on tendon, ligament, and bone healing. Studies suggest that BPC-157 may increase fibroblast density and enhance vascularization in injured connective tissues, potentially improving recovery in preclinical models.
4. Antioxidant Properties:
   BPC-157 has demonstrated antioxidant properties in several research models, reducing markers of oxidative stress. These properties are currently being explored in gastrointestinal health studies.
5. Drug Interaction and Safety Studies:
   In preclinical research, BPC-157 has been evaluated for its potential to mitigate drug-induced side effects, particularly related to gastrointestinal and cardiovascular stress caused by certain medications. However, these studies remain preliminary and are limited to research settings.

Disclaimer:

This product is strictly for research purposes only and is not approved for human or veterinary use. It should be handled in accordance with all applicable research protocols and institutional guidelines. Bodily introduction of this product in humans or animals is prohibited by law. BPC-157 has not been evaluated by the FDA and is not intended to diagnose, treat, cure, or prevent any disease.

FDA Compliance Statement: BPC-157 is designated for research use only (RUO) and is not intended for diagnostic or therapeutic use. This product must be handled exclusively by qualified professionals in controlled laboratory settings. Misbranding, mislabeling, or misuse of this product is prohibited under FDA regulations.